| 期刊ISSN: | 2052-1707 |
|---|---|
| E-ISSN: | |
| 影响因子: | 2.9 |
| 自引率: | 0% |
| 检索数据库: | |
| 出版语言: | 英文 |
| 期刊分类: |
| 最新中科院SCI期刊分区(基础版) | |
|---|---|
|
大学学科
|
|
|
医学
四区
|
|
|
按学科分区
|
|
|
药理学
四区
|
|
|
Top期刊
否
|
|
|
综述期刊
否
|
|
| 最新中科院SCI期刊分区(升级版) | |
|---|---|
|
大学学科
|
|
|
按学科分区
|
|
|
Top期刊
|
|
|
综述期刊
|
|
| 出版信息 | |
|---|---|
| 出版商 |
Wiley-Blackwell
|
| 期刊官网 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2052-1707 |
| 涉及的研究方向 |
Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
|
| 年文章数 |
0
|
| 是否OA |
是
|
| APC费用 | |
| SCI期刊收录coverage | |
| 期刊简介 | |
|---|---|
|
PR&P is jointly published by the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS), and Wiley. PR&P is a bi-monthly open access journal that publishes a range of article types, including: target validation (preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development); drug discovery reviews (strategy, hypotheses, and data resulting in a successful therapeutic drug); frontiers in translational medicine (drug and target validation for an unmet therapeutic need); pharmacological hypotheses (reviews that are oriented to inform a novel hypothesis); and replication studies (work that refutes key findings [failed replication] and work that validates key findings). PR&P publishes papers submitted directly to the journal and those referred from the journals of ASPET and the BPS
|
|
| Cite Score相关 | |||
|---|---|---|---|
| Cite Score | SJR | SNIP | 排名 |
EI Compendex,Scopus,IEEE Xplore
2026年智能系统控制、优化与应用国际学术会议(ISCOA 2026)985主办
IEEE出版
EI Compendex,Scopus,IEEE Xplore
第二届先进计算与智能机器人应用国际学术会议 (ACIRA 2026)IEEE出版
985主办
EI Compendex,Scopus,IEEE Xplore
第三届大数据分析与人工智能应用国际学术会议(BDAIA 2026)交叉学科
IEEE出版
EI Compendex,Scopus,IEEE Xplore
第二届AI赋能图像处理与计算机视觉技术国际学术研讨会(AIPCVT 2026)IEEE出版
多届检索